Oculus Innovative Sciences Inc. (NASDAQ:OCLS) shares saw unusually-strong trading volume on Monday . Approximately 66,099 shares were traded during trading, an increase of 31% from the previous session’s volume of 50,561 shares.The stock last traded at $3.95 and had previously closed at $4.29.

Separately, Maxim Group restated a “buy” rating and set a $3.00 price objective on shares of Oculus Innovative Sciences in a report on Friday, June 17th.

The stock has a 50 day moving average of $4.41 and a 200-day moving average of $4.86. The stock’s market capitalization is $16.38 million.

Oculus Innovative Sciences (NASDAQ:OCLS) last issued its earnings results on Thursday, July 28th. The company reported ($0.61) earnings per share (EPS) for the quarter. Equities research analysts expect that Oculus Innovative Sciences Inc. will post ($0.37) earnings per share for the current year.

Oculus Innovative Sciences, Inc is a specialty device and pharmaceutical company. The Company develops and markets solutions for the treatment of dermatological conditions and advanced tissue care in both humans and animals. The Company offers wound care products which are sold into the human and animal healthcare markets in the United States, Mexico and Europe.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.